I48 I63
Conditions
Interventions
Group 1: Planned examinations as part of the study: TTE and TEE 6 weeks, 6 months, 1, 2, 3, 4 and 5 years after the intervention
Sponsors
Helios Klinikum Pirna
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Presence of non-valvular paroxysmal, persistent or permanent atrial fibrillation Age over 18 years Written consent
Exclusion criteria
Exclusion criteria: Malignant tumor disease with life expectancy <12 months Pregnancy Patients who are unable to give the written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this register is, on the one hand, to analyze the safety and effectiveness of the procedure in patients with a high risk of bleeding in everyday clinical practice and, on the other hand, to evaluate hemorrhagic and thromboembolic events over the long term. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate hemorrhagic and thromboembolic events in long term follow up | — |
Countries
Germany
Contacts
Public ContactLucie Kretzler
Berlin Institute of Health (BIH)
Outcome results
None listed